Create Free Account

By creating account you will get access to hot stocks & personalised emails

Proteomics Intl Labs Ltd

Healthcare AU PIQ

1.05AUD
-0.01(0.94%)

Last update at 2024-05-16T00:51:00Z

Day Range

1.051.07
LowHigh

52 Week Range

0.701.40
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Income before tax -6.23431M -4.97296M -2.85966M -1.74377M -2.08027M
Minority interest - - - - -
Net income -6.23431M -4.97296M -2.85966M -1.74377M -2.10733M
Selling general administrative 5.11M 4.36M 2.87M 2.24M 2.16M
Selling and marketing expenses - 0.12M 0.06M 0.08M 0.23M
Gross profit -1.61511M -0.56862M 0.50M 0.58M 1.47M
Reconciled depreciation 0.53M 0.42M 0.37M 0.36M 0.19M
Ebit -8.82815M -4.97251M -2.85956M -1.73486M -2.05322M
Ebitda -8.29862M -4.55565M -2.48704M -1.37116M -1.86492M
Depreciation and amortization 0.53M 0.42M 0.37M 0.36M 0.19M
Non operating income net other - - - - -
Operating income -6.36560M -4.97728M -3.08268M -1.99821M -2.05322M
Other operating expenses 4.86M 4.29M 3.98M 2.80M 4.54M
Interest expense - 0.00045M 0.00010M 0.00891M 0.03M
Tax provision 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Interest income 0.14M 0.00544M 0.01M 0.02M 0.28M
Net interest income 0.14M 0.00275M 0.00805M 0.01M 0.02M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -0.14836M 1.94M 1.64M 1.58M 0.03M
Total revenue 0.73M 1.49M 1.31M 1.42M 1.47M
Total operating expenses 9.55M 8.41M 5.82M 4.74M 4.54M
Cost of revenue 2.35M 2.06M 0.81M 0.84M 0.81M
Total other income expense net 2.45M 1.94M 1.64M 1.57M -0.02706M
Discontinued operations - - - - -
Net income from continuing ops -6.23431M -4.97296M -2.85966M -1.74377M -2.08027M
Net income applicable to common shares -6.17657M -4.97296M -2.85966M -1.74377M -2.08027M
Preferred stock and other adjustments - - - - -
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Total assets 10.08M 5.40M 8.60M 5.55M 3.62M
Intangible assets 0.00101M 0.00101M 0.00101M 0.00101M 0.00101M
Earning assets - - - - -
Other current assets 1.97M 1.73M 1.30M 1.33M 1.19M
Total liab 1.75M 2.00M 0.99M 1.12M 0.63M
Total stockholder equity 8.38M 3.39M 7.61M 4.44M 2.99M
Deferred long term liab - - - - -
Other current liab 0.55M 1.18M 0.30M 0.44M 0.18M
Common stock 30.18M 19.34M 19.10M 13.39M 10.54M
Capital stock 30.18M 19.34M 19.10M 13.39M 10.54M
Retained earnings -23.62758M -17.63007M -12.65711M -10.00774M -8.26397M
Other liab - 0.30M 0.21M 0.43M 0.07M
Good will - - - - -
Other assets 0.06M 0.06M 0.00000M 0.00000M 0.16M
Cash 6.03M 2.11M 5.60M 2.37M 1.51M
Cash and equivalents 5.79M 1.00M 5.05M 0.05M 1.05M
Total current liabilities 1.10M 1.70M 0.78M 0.62M 0.55M
Current deferred revenue 0.37M 0.36M 0.27M -0.06380M -
Net debt -5.96323M -2.11151M -5.53579M -2.23218M -1.34651M
Short term debt 0.03M -0.35598M 0.07M 0.06M 0.15M
Short long term debt - - - - -
Short long term debt total 0.06M 0.06M 0.07M 0.13M 0.16M
Other stockholder equity -6.55268M -1.71084M -6.43812M -3.38380M 0.71M
Property plant equipment 1.69M 0.97M 1.26M 1.44M 0.21M
Total current assets 8.33M 4.36M 7.34M 4.12M 3.24M
Long term investments - - - - 0.16M
Net tangible assets - 3.39M 7.61M 4.44M 2.99M
Short term investments - - - - -
Net receivables 0.21M 0.44M 0.30M 0.36M 0.50M
Long term debt - - - - 0.00000M
Inventory 0.12M 0.08M 0.13M 0.06M 0.04M
Accounts payable 0.15M 0.52M 0.14M 0.18M 0.22M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 1.83M 1.68M 1.17M 1.05M 0.71M
Additional paid in capital - - - - -
Common stock total equity - - - 13.39M 10.54M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.06M 0.06M -1.26180M -1.43711M 0.38M
Deferred long term asset charges - - - - -
Non current assets total 1.75M 1.03M 1.26M 1.44M 0.38M
Capital lease obligations 0.06M - 0.07M 0.13M 0.16M
Long term debt total 0.03M 0.00000M 0.00000M 0.07M 0.02M
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Investments -1.16513M -0.12946M -0.19100M -1.58613M 0.93M
Change to liabilities 0.00000M 1.01M -0.14885M 0.61M -0.08707M
Total cashflows from investing activities -1.16513M -0.12946M -0.19100M -1.58613M 0.89M
Net borrowings - -0.06905M -0.06380M -0.16492M -0.14750M
Total cash from financing activities 10.77M 0.18M 5.64M 2.82M -0.02875M
Change to operating activities - -0.36195M 0.04M 0.04M 0.87M
Net income -6.17657M -4.97296M -2.85966M -1.74377M -2.08027M
Change in cash 3.92M -3.49332M 3.24M 0.85M -0.80535M
Begin period cash flow 2.11M 5.60M 2.37M 1.51M 2.32M
End period cash flow 6.03M 2.11M 5.60M 2.37M 1.51M
Total cash from operating activities -5.69291M -3.53996M -2.20907M -0.38451M -1.66701M
Issuance of capital stock 10.84M 0.25M 5.70M 3.05M 0.12M
Depreciation 0.53M 0.42M 0.37M 0.36M 0.19M
Other cashflows from investing activities 0.05M 0.00000M 0.01M -0.12782M -0.12782M
Dividends paid - - - - -
Change to inventory - - - - -
Change to account receivables 0.29M -0.13908M 0.06M 0.14M 0.10M
Sale purchase of stock 10.84M 0.25M 5.70M 3.05M 0.12M
Other cashflows from financing activities -0.06551M -0.06905M -0.06380M -0.06880M 0.89M
Change to netincome 0.32M 0.51M 0.32M 0.21M -0.65696M
Capital expenditures 1.22M 0.13M 0.21M 1.59M 0.04M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.29M -0.13908M 0.06M 0.14M 0.13M
Stock based compensation 0.32M 0.51M 0.33M 0.15M -
Other non cash items -0.04587M 1.02M 0.28M 1.00M 1.89M
Free cash flow -6.91082M -3.66942M -2.41424M -1.97064M -0.03799M

Fundamentals

  • Previous Close 1.06
  • Market Cap137.44M
  • Volume38493
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-5.64917M
  • Revenue TTM3.03M
  • Revenue Per Share TTM0.03
  • Gross Profit TTM 0.84M
  • Diluted EPS TTM-0.05

Peer Comparison

Sector: Healthcare Industry: Biotechnology

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
PIQ
Proteomics Intl Labs Ltd		 -0.01 0.94% 1.05 - - 50.73 29.60 264.01 -18.9455
CSL
CSL Ltd		 3.56 1.26% 286.61 37.27 31.35 9.60 5.16 10.91 34.93
TLX
Telix Pharmaceuticals Ltd		 0.26 1.69% 15.32 769.50 21.01 8.47 28.69 8.21 177.65
NEU
Neuren Pharmaceuticals Ltd		 0.56 2.62% 21.90 18.17 38.46 11.63 13.15 10.65 12.39
CU6
Clarity Pharmaceuticals Ltd		 0.16 4.17% 4.00 - - 85.90 15.59 - -18.7407

Reports Covered

Stock Research & News

View All

Profile

Proteomics International Laboratories Limited operates as a medical technology company with a focus on the area of proteomics. It provides PromarkerD, a predictive test for diabetic kidney disease; and develops diagnostic tests for endometriosis and giardia. The company also offers analytical services, including specialist contract research. The company was founded in 2001 and is based in Perth, Australia.

Proteomics Intl Labs Ltd

QEII Medical Centre, Perth, WA, Australia, 6009

Key Executives

Name Title Year Born
Dr. Richard John Lipscombe M.A., MA (Oxford), Ph.D., Ph.D., (London) Co-Founder, MD & Director NA
Ms. Jacqueline Gray Chief Financial Officer NA
Mr. Vikesh Malik Chief Commercialisation Officer NA
Mr. John Chuck Morrison Head of Bus. Devel. NA
Dr. Scott Bringans Head of Research NA
Dr. Pearl Tan Head of Logistics NA
Dr. Kirsten Peters Head of Clinical Studies NA
Ms. Karen Teresa Logan B.Com., FCIS, BCom, DipAppCorpGov, FFin, ACIS, AGI Company Sec. NA
Mr. John Chuck Morrison Head of Business Development NA
Ms. Karen Teresa Logan ACIS, B.Com., BCom, DipAppCorpGov, F Fin, FCIS, FC Company Secretary NA

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).

Our Company

Useful Links

Contact Us

Market Research

Our Company

Useful Links

Contact Us

Disclaimer

The information given by Kalkine Pty Ltd ABN34 154 808 312 (Australian Financial Services License Number 425376) on this website is general information or advice only.

It does not take into account any of your personal objectives, circumstances or needs. Choosing an investment is an important decision. If you do not feel confident making a decision based on the recommendations Kalkine has made in our reports, you should consider obtaining personal advice from an authorised adviser.

There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. Terms & Conditions have been provided for our services, please go through them and also read our Financial Services Guide.

Our website may contain information on past performance of particular investments. Past performance is not an indicator of future performance. Hypothetical returns may not reflect actual performance. Any displays of potential investment opportunities are for sample purposes only and may not actually be available to investors.

The information on the website does not constitute an offer to sell securities or a solicitation of an offer to buy securities. Our reports contain general recommendations to invest in securities.

Copyright 2024 Krish Capital Pty. Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.